RHUMBLINE ADVISERS - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 61 filers reported holding EDGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$21,000
-86.8%
17,552
+3.7%
0.00%
Q4 2017$159,000
-27.1%
16,932
-16.5%
0.00%
Q3 2017$218,000
+6.3%
20,285
+1.6%
0.00%
Q2 2017$205,000
+34.0%
19,960
+19.1%
0.00%
Q1 2017$153,000
-23.5%
16,765
+4.8%
0.00%
-100.0%
Q4 2016$200,000
+28.2%
16,001
+7.0%
0.00%
Q3 2016$156,000
+16.4%
14,950
+12.8%
0.00%
Q2 2016$134,00013,2500.00%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$24,058,00016.90%
VHCP Management II, LLC 1,933,582$19,839,0007.92%
ACUTA CAPITAL PARTNERS, LLC 1,504,612$15,437,0004.32%
Opaleye Management Inc. 130,000$1,334,0000.56%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,539,0000.26%
DAFNA Capital Management LLC 19,400$199,0000.14%
REGENTATLANTIC CAPITAL LLC 134,900$1,384,0000.13%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 14,400$148,0000.10%
TFS CAPITAL LLC 20,080$206,0000.08%
EAGLE ASSET MANAGEMENT INC 901,359$9,247,0000.06%
View complete list of EDGE THERAPEUTICS INC shareholders